SEC Form 4 · accession 0001213900-26-094862
MEDIFAST INC · MED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Parsa Kiai
Director
Period of report
Aug 26, 2026
Accepted (ET)
Aug 28, 2026 · 12:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000910329
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3,F4 | Aug 26, 2026 | P | 41,975 | $12.2632 | A | 707,492 | I | Notes |
| Common StockF2,F3,F4 | Aug 26, 2026 | P | 1,175 | $12.2632 | A | 20,270 | I | Notes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
- F2Ownership of Steamboat Capital Partners II, LP (II).
- F3Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai ("Kiai") is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
- F4This is an average price. Actual prices paid for the shares purchased on 8/26/26 and reported on this line range from $12.12 to $12.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.